Powered by: Motilal Oswal
2026-02-21 11:49:16 am | Source: Motilal Oswal Financial Services Ltd0
Neutral Alkyl Amines Chemicals Ltd for the Target Rs.1,730 by Motilal Oswal Financial Services Ltd
Neutral Alkyl Amines Chemicals Ltd for the Target Rs.1,730 by Motilal Oswal Financial Services Ltd

Muted performance amid demand and cost pressures

Earnings in line

* Alkyl Amines Chemicals (AACL) reported a muted operating performance in 3QFY26 as EBITDA declined 6% YoY. Further, higher raw material costs (gross margin contracted 50bp YoY) resulted in a marginal 20bp YoY contraction in EBITDA margins to 19%.

* The momentum is expected to remain muted in the near term due to prevailing demand softness across key end-user industries and heightened competitive intensity from Chinese manufacturers.

* We broadly maintain our earnings estimates and value the stock at 38x FY28E EPS to arrive at a TP of INR1,730. Reiterate Neutral.

Muted operating performance

* In 3QFY26, revenue came in at INR3.5b (est. of INR3.7b), down 5%/9% YoY/QoQ, while gross margin stood at 48%, down 50bpsYoY and up 60bp QoQ.

* In 3QFY26, EBITDA margin stood at 19%, contracting 20bp YoY but expanding 90bp QoQ.

* EBITDA stood at INR672m (est. in line), declining 6% YoY and 4% QoQ.

* Adjusted PAT stood at INR423m (est. in line), declining 3% YoY and 2% QoQ.

* In 9MFY26, Revenue/EBITDA/Adj. PAT declined 3%/4%/4% YoY at INR11.5b/INR2.1b/INR1.3b.

Valuation and view

* We expect short-term headwinds to persist, with volumes likely to be affected by global demand softness and weakness across key end-user industries, along with continued pricing pressure due to heightened competition from Chinese manufacturers.

* However, the long-term outlook remains positive, supported by AACL’s strengthening global presence through the development of efficient, costeffective processes for high-grade and ultra-pure specialty products. The planned commercialization of a new product at the Kurkumbh facility, along with additional products in the R&D pipeline, should drive the next phase of growth.

* We estimate a CAGR of 5%/7%/8% in revenue/EBITDA/PAT over FY25-28 and maintain our earnings estimates. We value the stock at 38x FY28E EPS to arrive at a TP of INR1,730. Reiterate Neutral.

       

 

 

For More Research Reports : Click Here 

For More Motilal Oswal Securities Ltd Disclaimer
http://www.motilaloswal.com/MOSLdisclaimer/disclaimer.html
SEBI Registration number is INH000000412

 

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here